Chadi Nabhan

Also affiliated with Laguna College of Art and Design, Laguna Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Outcomes of COVID-19 in patients with CLL: a multicenter international experience”.

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

13.4DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma

Journal of Clinical Investigation(2024)10.1172/jci176230

N/A

0.524DataRank · unranked

32 citations

Pedro C. Barata, Andrew Elliott, Mehmet Asım Bilen, Earle F. Burgess, Toni K. Choueiri +16 more

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00797-0

N/A

0.477DataRank · unranked

23 citations

Allison Makovec, Andrew Elliott, Samuel Kellen, John R. Lozada, Ali T. Arafa +19 more

S1314 correlative analysis of ATM, RB1, ERCC2, and FANCC mutations and pathologic complete response (pT0) at cystectomy after neoadjuvant chemotherapy (NAC) in patients with muscle invasive bladder cancer (MIBC): Implications for bladder preservation.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4581

N/A

0.312DataRank · unranked

7 citations

Catherine M. Tangen, Melissa Plets, Rutika Kokate, Joanne Xiu, Chadi Nabhan +9 more

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status

ESMO Gastrointestinal Oncology(2024)10.1016/j.esmogo.2024.100042

N/A

0.208DataRank · unranked

3 citations

Yasmine Baca, Joanne Xiu, Phillip Walker, Gulam A. Manji, Sepideh Gholami +13 more

Assessment of the Efficacy of Therapies Following Venetoclax Discontinuation in CLL Reveals BTK Inhibition as an Effective Strategy

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3815

N/A

0DataRank · unranked

116 citations

Lindsey E. Roeker, Ryan Jacobs, Brian T. Hill, Nicole Lamanna, Danielle M. Brander +49 more

The Inflation Reduction Act and Etanercept

Arthritis & Rheumatology(2025)10.1002/art.43153

N/A

0DataRank · unranked

0 citations

Jason B. Gibbons, Chadi Nabhan, Kenneth R. Carson, June M. McKoy, Kevin Knopf +2 more